Literature DB >> 24400873

Parametric likelihood inference for interval censored competing risks data.

Michael G Hudgens1, Chenxi Li, Jason P Fine.   

Abstract

Parametric estimation of the cumulative incidence function (CIF) is considered for competing risks data subject to interval censoring. Existing parametric models of the CIF for right censored competing risks data are adapted to the general case of interval censoring. Maximum likelihood estimators for the CIF are considered under the assumed models, extending earlier work on nonparametric estimation. A simple naive likelihood estimator is also considered that utilizes only part of the observed data. The naive estimator enables separate estimation of models for each cause, unlike full maximum likelihood in which all models are fit simultaneously. The naive likelihood is shown to be valid under mixed case interval censoring, but not under an independent inspection process model, in contrast with full maximum likelihood which is valid under both interval censoring models. In simulations, the naive estimator is shown to perform well and yield comparable efficiency to the full likelihood estimator in some settings. The methods are applied to data from a large, recent randomized clinical trial for the prevention of mother-to-child transmission of HIV.
© 2014, The International Biometric Society.

Entities:  

Keywords:  Competing risks; Cumulative incidence function; Gompertz; HIV/AIDS; Maximum likelihood

Mesh:

Year:  2014        PMID: 24400873      PMCID: PMC4004384          DOI: 10.1111/biom.12109

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Nonparametric maximum likelihood estimation for competing risks survival data subject to interval censoring and truncation.

Authors:  M G Hudgens; G A Satten; I M Longini
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  The validity of inferences based on incomplete observations in disease state models.

Authors:  J Grüger; R Kay; M Schumacher
Journal:  Biometrics       Date:  1991-06       Impact factor: 2.571

3.  CURRENT STATUS DATA WITH COMPETING RISKS: LIMITING DISTRIBUTION OF THE MLE.

Authors:  Piet Groeneboom; Marloes H Maathuis; Jon A Wellner
Journal:  Ann Stat       Date:  2008-01-01       Impact factor: 4.028

4.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

5.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Authors:  Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

  5 in total
  13 in total

1.  Cause-Specific Hazard Regression for Competing Risks Data Under Interval Censoring and Left Truncation.

Authors:  Chenxi Li
Journal:  Comput Stat Data Anal       Date:  2016-07-14       Impact factor: 1.681

2.  Semiparametric regression analysis of interval-censored competing risks data.

Authors:  Lu Mao; Dan-Yu Lin; Donglin Zeng
Journal:  Biometrics       Date:  2017-02-17       Impact factor: 2.571

3.  Semiparametric regression on cumulative incidence function with interval-censored competing risks data.

Authors:  Giorgos Bakoyannis; Menggang Yu; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2017-06-12       Impact factor: 2.373

4.  Transitions in pregnancy planning in women recruited for a large prospective cohort study.

Authors:  U Luderer; T Li; J P Fine; R F Hamman; J B Stanford; D Baker
Journal:  Hum Reprod       Date:  2017-06-01       Impact factor: 6.918

5.  Analysis of interval-censored competing risks data under missing causes.

Authors:  Debanjan Mitra; Ujjwal Das; Kalyan Das
Journal:  J Appl Stat       Date:  2019-07-16       Impact factor: 1.416

6.  A progressive three-state model to estimate time to cancer: a likelihood-based approach.

Authors:  Eddymurphy U Akwiwu; Thomas Klausch; Henriette C Jodal; Beatriz Carvalho; Magnus Løberg; Mette Kalager; Johannes Berkhof; Veerle M H Coupé
Journal:  BMC Med Res Methodol       Date:  2022-06-27       Impact factor: 4.612

7.  Inference for set-based effects in genetic association studies with interval-censored outcomes.

Authors:  Ryan Sun; Liang Zhu; Yimei Li; Yutaka Yasui; Leslie Robison
Journal:  Biometrics       Date:  2022-02-14       Impact factor: 1.701

8.  The Fine-Gray Model Under Interval Censored Competing Risks Data.

Authors:  Chenxi Li
Journal:  J Multivar Anal       Date:  2016-01-01       Impact factor: 1.473

9.  Time to Osteoporosis and Major Fracture in Older Men: The MrOS Study.

Authors:  Margaret L Gourlay; Robert A Overman; Jason P Fine; Guillaume Filteau; Peggy M Cawthon; John T Schousboe; Eric S Orwoll; Timothy J Wilt; Tuan V Nguyen; Nancy E Lane; Pawel Szulc; Brent C Taylor; Thuy-Tien Dam; Carrie M Nielson; Jane A Cauley; Elizabeth Barrett-Connor; Howard A Fink; Jodi A Lapidus; Deborah M Kado; Susan J Diem; Kristine E Ensrud
Journal:  Am J Prev Med       Date:  2016-01-25       Impact factor: 5.043

10.  Multi-marker genetic association and interaction tests with interval-censored survival outcomes.

Authors:  Di Wu; Chenxi Li; Qing Lu
Journal:  Genet Epidemiol       Date:  2021-09-02       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.